Biologics, orphan drugs, and precision medicine are on the rise, and that means some big changes for drug development and manufacturing companies.
Help sponsors design a more holistic strategy to their managing the clinical supply returns process.
Engaging clinical supply management and forecasting adds value by evaluating different response strategies and contingency plans and can identify supply solutions that minimize or even potentially avoid supply chain disruptions.
How sponsors can work effectively with clinical suppliers for accurate forecasting and comparator sourcing to avoid delays in clinical supply.
In addition to careful adherence with all applicable regulatory and Customs requirements, sponsors should understand and be sensitive to the cultural and business norms of each country included in their study.
A US biopharmaceutical company approached Almac to assist with the EU product launch of their high value, orphan drug product.
Learn more about how free trade zones can offer cost-efficient ways to manage your clinical trial.
See how this service can benefit you with shorter lead time, less waste, less stock out risk and no booklet labels.
How utilizing a global network of leading manufacturers, wholesalers, and carefully selected QA-qualified healthcare professionals can provide cost-effective access to virtually any product.
Hear insights from Sam Herbert, president of World Courier, regarding how the evolution of the supply chain in traditional small and large molecules is a handoff from clinical partners into commercial partners.
Contracting an in-country clinical depot helps bring costs and timelines under control.
How your manufacturing, packaging, serialization, and clinical distribution can benefit with a contract partner.
